RXST
Price
$8.89
Change
+$0.19 (+2.18%)
Updated
Sep 3 closing price
Capitalization
363.33M
63 days until earnings call
TRUMY
Price
$17.90
Change
-$0.07 (-0.39%)
Updated
Sep 2 closing price
Capitalization
26.39B
64 days until earnings call
Interact to see
Advertisement

RXST vs TRUMY

Header iconRXST vs TRUMY Comparison
Open Charts RXST vs TRUMYBanner chart's image
RxSight
Price$8.89
Change+$0.19 (+2.18%)
Volume$1.14M
Capitalization363.33M
Terumo
Price$17.90
Change-$0.07 (-0.39%)
Volume$358.85K
Capitalization26.39B
RXST vs TRUMY Comparison Chart in %
Loading...
RXST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RXST vs. TRUMY commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXST is a Buy and TRUMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (RXST: $8.88 vs. TRUMY: $17.86)
Brand notoriety: RXST and TRUMY are both not notable
RXST represents the Medical/Nursing Services, while TRUMY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RXST: 71% vs. TRUMY: 80%
Market capitalization -- RXST: $363.33M vs. TRUMY: $26.39B
RXST [@Medical/Nursing Services] is valued at $363.33M. TRUMY’s [@Pharmaceuticals: Other] market capitalization is $26.39B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.05B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.15B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXST’s FA Score shows that 0 FA rating(s) are green whileTRUMY’s FA Score has 0 green FA rating(s).

  • RXST’s FA Score: 0 green, 5 red.
  • TRUMY’s FA Score: 0 green, 5 red.
According to our system of comparison, TRUMY is a better buy in the long-term than RXST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXST’s TA Score shows that 4 TA indicator(s) are bullish while TRUMY’s TA Score has 5 bullish TA indicator(s).

  • RXST’s TA Score: 4 bullish, 2 bearish.
  • TRUMY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RXST is a better buy in the short-term than TRUMY.

Price Growth

RXST (@Medical/Nursing Services) experienced а +3.86% price change this week, while TRUMY (@Pharmaceuticals: Other) price change was -1.65% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.10%. For the same industry, the average monthly price growth was +1.77%, and the average quarterly price growth was +24.12%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.10%. For the same industry, the average monthly price growth was +6.91%, and the average quarterly price growth was +33.60%.

Reported Earning Dates

RXST is expected to report earnings on Nov 06, 2025.

TRUMY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.10% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-2.10% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRUMY($26.4B) has a higher market cap than RXST($363M). TRUMY YTD gains are higher at: -8.410 vs. RXST (-74.171). TRUMY has higher annual earnings (EBITDA): 247B vs. RXST (-28.93M). TRUMY has more cash in the bank: 195B vs. RXST (227M). RXST has less debt than TRUMY: RXST (11.7M) vs TRUMY (175B). TRUMY has higher revenues than RXST: TRUMY (987B) vs RXST (147M).
RXSTTRUMYRXST / TRUMY
Capitalization363M26.4B1%
EBITDA-28.93M247B-0%
Gain YTD-74.171-8.410882%
P/E RatioN/A33.26-
Revenue147M987B0%
Total Cash227M195B0%
Total Debt11.7M175B0%
FUNDAMENTALS RATINGS
TRUMY: Fundamental Ratings
TRUMY
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
53
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RXSTTRUMY
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 8 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
RXST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
RDNT.X0.0205970.000672
+3.37%
Radiant Capital cryptocurrency
SHIB.X0.000012N/A
+2.83%
Shiba Inu cryptocurrency
PHA.X0.1035470.002179
+2.15%
Phala Network cryptocurrency
RGT.X0.0672220.000310
+0.46%
Rari Governance Token cryptocurrency
IOTX.X0.027532-0.000257
-0.92%
IoTeX cryptocurrency

TRUMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-0.22%
HOCPY - TRUMY
51%
Loosely correlated
+1.96%
SSMXY - TRUMY
45%
Loosely correlated
+1.42%
SMTI - TRUMY
43%
Loosely correlated
-3.23%
OLYMY - TRUMY
40%
Loosely correlated
+0.33%
AZTA - TRUMY
39%
Loosely correlated
-2.59%
More